Metraipolis › archive › dc_438da067dd4f

Safety and Pharmacokinetics of Nirsevimab in Japanese Infants: Primary Analysis of the Open-Label JUBILUS Trial — Europe PMC PMID:41874424

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41874424
DOI
10.1093/jpids/piag008
License (as archived)
solo-consultazione
Archived
2026-11-06T08:51:15.244Z
SHA-256 of the archived text
88fd6f8c91684731e1cd22719dea98577b49a328c13d63787c3b08eed078a84d
Stable URL of this page
https://metraipolis.com/documento/dc_438da067dd4f

How to cite

Safety and Pharmacokinetics of Nirsevimab in Japanese Infants: Primary Analysis of the Open-Label JUBILUS Trial — Europe PMC PMID:41874424 — Europe PMC (en), https://europepmc.org/article/MED/41874424 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_438da067dd4f (Metraipolis archive dc_438da067dd4f, sha256 88fd6f8c91684731e1cd22719dea98577b49a328c13d63787c3b08eed078a84d)
BibTeX
@misc{dc438da067dd4f,
  title = {Safety and Pharmacokinetics of Nirsevimab in Japanese Infants: Primary Analysis of the Open-Label JUBILUS Trial — Europe PMC PMID:41874424},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41874424},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_438da067dd4f; sha256 88fd6f8c91684731e1cd22719dea98577b49a328c13d63787c3b08eed078a84d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41874424. Agents can read the archived copy with the MCP tool read_document.